• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

白细胞介素-2联合白细胞介素-15增强患者自体自然杀伤细胞上NKG2D受体的表达,通过丝裂原活化蛋白激酶信号通路抑制肾母细胞瘤。

IL-2 Combined with IL-15 Enhanced the Expression of NKG2D Receptor on Patient Autologous NK Cells to Inhibit Wilms' Tumor via MAPK Signaling Pathway.

作者信息

Li Yanping, Li Yonglin, Xiang Bin, Tian Xiaomao, Shi Qinlin, Liu Feng, Lin Tao, Wei Guanghui

机构信息

Ministry of Education Key Laboratory of Child Development and Disorders, Chongqing Key Laboratory of Pediatrics, Chongqing Key Laboratory of Children Urogenital Development and Tissue Engineering, China International Science and Technology Cooperation Base of Child Development and Critical Disorders, Pediatric Research Institute, Children's Hospital of Chongqing Medical University, Chongqing 400014, China.

Department of Pediatric Urology Surgery, Children's Hospital of Chongqing Medical University, Chongqing 400014, China.

出版信息

J Oncol. 2022 Sep 30;2022:4544773. doi: 10.1155/2022/4544773. eCollection 2022.

DOI:10.1155/2022/4544773
PMID:36213822
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9546681/
Abstract

OBJECTIVE

The dysfunction of immune surveillance, a hot spot in cancer research, could lead to the occurrence and development in multicancers. However, the potential mechanisms of immunity in Wilms' tumor (WT) remain unclear on Wilms' tumor (WT). In this study, we aim to investigate the immune cell in WT and explore the underlying treatment strategy.

METHOD

We quantified stromal and immune scores by using ESTIMATE algorithm based on gene expression matrix of WT patients in TCGA and GEO databases. Different expression genes (DEGs) and functional enrichments were analyzed by R studio and DAVID tools. Flow cytometry, immunofluorescence staining, ELISA assay, and qRT-PCR were used for detecting the NK cells, cytotoxic cytokines (INF-, PRF, and GZMB), and NK cell receptor expression, respectively. WT patient autologous NK cells were stimulated by IL-2 and IL-15, and the cytotoxicity of NK cells against WT cell lines was detected by LDH assay. Western blot experiment was used for measuring the MAPK signaling pathway protein maker in NK cells.

RESULTS

ESTIMATE indicated that WT tissue had a lower immune score than adjacent kidney tissue. Meanwhile, the low immune score group was associated with poorly outcomes. DEG functional enrichment analysis showed that NK cell-mediated cytotoxicity was significantly different in low and high immune score groups. Although few of proportion of NK cells in WT patients were increased, most of that were significantly lower than normal children. Moreover, the proportion of NK cells and the expression level of INF-, PRF, and GZMB in WT tissue were lower than adjacent kidney tissue. Importantly, the NKG2D expression level of NK cells was significantly lower in WT tissue. Furthermore, in vitro, compared with uncultured NK cells, IL-2 and IL-15 could effectively enhance the cytotoxicity of NK cells on killing the WT cell lines. The FACS and WB results showed that the NKG2D and p-PI3K ratio PI3K, MEK1/2, and p-ERK1/2 ratio ERK1/2 were significantly increased in IL-2 and IL15 group compared with uncultured groups.

CONCLUSION

The abnormal NK cell-mediated cytotoxicity may cause the occurrence of WT. Costimulation of WT patients autologous NK cells could effectively enhance the antitumor reaction which involved in activation of NKG2D-mediated MAPK signaling pathway.

摘要

目的

免疫监视功能障碍是癌症研究的热点,可导致多种癌症的发生和发展。然而,肾母细胞瘤(WT)的免疫潜在机制仍不清楚。在本研究中,我们旨在研究WT中的免疫细胞并探索潜在的治疗策略。

方法

我们使用ESTIMATE算法基于TCGA和GEO数据库中WT患者的基因表达矩阵对基质和免疫评分进行量化。通过R studio和DAVID工具分析差异表达基因(DEG)和功能富集情况。分别使用流式细胞术、免疫荧光染色、ELISA检测和qRT-PCR检测NK细胞、细胞毒性细胞因子(INF-、PRF和GZMB)以及NK细胞受体的表达。WT患者自体NK细胞用IL-2和IL-15刺激,通过LDH检测法检测NK细胞对WT细胞系的细胞毒性。蛋白质印迹实验用于检测NK细胞中MAPK信号通路蛋白标志物。

结果

ESTIMATE表明WT组织的免疫评分低于相邻肾组织。同时,低免疫评分组与较差的预后相关。DEG功能富集分析表明,NK细胞介导的细胞毒性在低免疫评分组和高免疫评分组中有显著差异。虽然WT患者中NK细胞比例有所增加,但大多数仍显著低于正常儿童。此外,WT组织中NK细胞比例以及INF-、PRF和GZMB的表达水平均低于相邻肾组织。重要的是,WT组织中NK细胞的NKG2D表达水平显著降低。此外,在体外,与未培养的NK细胞相比,IL-2和IL-15可有效增强NK细胞对WT细胞系的杀伤细胞毒性。流式细胞术和蛋白质印迹结果显示,与未培养组相比,IL-2和IL-15组中NKG2D以及p-PI3K与PI3K的比值、MEK1/2和p-ERK1/2与ERK1/2的比值显著增加。

结论

异常的NK细胞介导的细胞毒性可能导致WT的发生。WT患者自体NK细胞的共刺激可有效增强抗肿瘤反应,这涉及NKG2D介导的MAPK信号通路的激活。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/769e/9546681/9e50ced3005c/JO2022-4544773.008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/769e/9546681/4bb2c557701f/JO2022-4544773.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/769e/9546681/d9af00d72c96/JO2022-4544773.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/769e/9546681/df8f488097f4/JO2022-4544773.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/769e/9546681/7dcf0ba0c52a/JO2022-4544773.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/769e/9546681/5cb08462edcd/JO2022-4544773.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/769e/9546681/6d68d2efcabd/JO2022-4544773.006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/769e/9546681/fbb87f7966e3/JO2022-4544773.007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/769e/9546681/9e50ced3005c/JO2022-4544773.008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/769e/9546681/4bb2c557701f/JO2022-4544773.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/769e/9546681/d9af00d72c96/JO2022-4544773.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/769e/9546681/df8f488097f4/JO2022-4544773.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/769e/9546681/7dcf0ba0c52a/JO2022-4544773.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/769e/9546681/5cb08462edcd/JO2022-4544773.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/769e/9546681/6d68d2efcabd/JO2022-4544773.006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/769e/9546681/fbb87f7966e3/JO2022-4544773.007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/769e/9546681/9e50ced3005c/JO2022-4544773.008.jpg

相似文献

1
IL-2 Combined with IL-15 Enhanced the Expression of NKG2D Receptor on Patient Autologous NK Cells to Inhibit Wilms' Tumor via MAPK Signaling Pathway.白细胞介素-2联合白细胞介素-15增强患者自体自然杀伤细胞上NKG2D受体的表达,通过丝裂原活化蛋白激酶信号通路抑制肾母细胞瘤。
J Oncol. 2022 Sep 30;2022:4544773. doi: 10.1155/2022/4544773. eCollection 2022.
2
Engagement of TLR3, TLR7, and NKG2D regulate IFN-gamma secretion but not NKG2D-mediated cytotoxicity by human NK cells stimulated with suboptimal doses of IL-12.Toll样受体3(TLR3)、Toll样受体7(TLR7)和自然杀伤细胞2D(NKG2D)的激活可调节γ干扰素的分泌,但对次优剂量白细胞介素12刺激的人自然杀伤细胞介导的细胞毒性无影响。
J Immunol. 2007 Sep 15;179(6):3472-9. doi: 10.4049/jimmunol.179.6.3472.
3
The killing effect of Tanshinol on breast cancer cells: insight into the reversion of TGF-β1-mediated suppression of NK cell functions.丹参醇对乳腺癌细胞的杀伤作用:逆转 TGF-β1 介导的 NK 细胞功能抑制的研究。
Front Biosci (Landmark Ed). 2021 Nov 30;26(11):1106-1118. doi: 10.52586/5013.
4
CD4+CD25+Foxp3+ regulatory T cells suppress NKG2D-mediated NK cell cytotoxicity in peripheral blood.CD4+CD25+Foxp3+调节性T细胞抑制外周血中NKG2D介导的自然杀伤细胞的细胞毒性。
Medicine (Baltimore). 2019 May;98(22):e15722. doi: 10.1097/MD.0000000000015722.
5
Inhibition of IL-6-JAK/Stat3 signaling in castration-resistant prostate cancer cells enhances the NK cell-mediated cytotoxicity via alteration of PD-L1/NKG2D ligand levels.阻断白细胞介素 6-JAK/Stat3 信号通路可通过改变 PD-L1/NKG2D 配体水平增强去势抵抗性前列腺癌细胞的 NK 细胞介导的细胞毒性。
Mol Oncol. 2018 Mar;12(3):269-286. doi: 10.1002/1878-0261.12135. Epub 2018 Jan 24.
6
Optimization of Human NK Cell Manufacturing: Fully Automated Separation, Improved Ex Vivo Expansion Using IL-21 with Autologous Feeder Cells, and Generation of Anti-CD123-CAR-Expressing Effector Cells.人自然杀伤细胞制备的优化:全自动分离,使用 IL-21 和自体饲养细胞进行体外扩增的改进,以及生成表达抗 CD123-CAR 的效应细胞。
Hum Gene Ther. 2017 Oct;28(10):897-913. doi: 10.1089/hum.2017.157. Epub 2017 Aug 15.
7
GPR116 receptor regulates the antitumor function of NK cells via Gαq/HIF1α/NF-κB signaling pathway as a potential immune checkpoint.GPR116受体作为一种潜在的免疫检查点,通过Gαq/HIF1α/NF-κB信号通路调节自然杀伤细胞的抗肿瘤功能。
Cell Biosci. 2023 Mar 9;13(1):51. doi: 10.1186/s13578-023-01005-7.
8
Interleukin-18 synergism with interleukin-2 in cytotoxicity and NKG2D expression of human natural killer cells.白细胞介素-18与白细胞介素-2在人自然杀伤细胞的细胞毒性和NKG2D表达中的协同作用。
Asian Pac J Cancer Prev. 2014;15(18):7857-61. doi: 10.7314/apjcp.2014.15.18.7857.
9
4-1BB antibody enhances cytotoxic activity of natural killer cells against prostate cancer cells via NKG2D agonist combined with IL-27.4-1BB 抗体通过 NKG2D 激动剂与 IL-27 的联合增强自然杀伤细胞对前列腺癌细胞的细胞毒性活性。
Immunotherapy. 2022 Sep;14(13):1043-1053. doi: 10.2217/imt-2021-0232. Epub 2022 Jul 19.
10
In-vitro IL-2 or IFN-α-induced NKG2D and CD161 NK cell receptor expression indicates novel aspects of NK cell activation in metastatic melanoma patients.在体外培养的白细胞介素 2 或干扰素-α诱导的 NKG2D 和 CD161 NK 细胞受体表达表明转移性黑色素瘤患者 NK 细胞激活的新方面。
Melanoma Res. 2010 Dec;20(6):459-67. doi: 10.1097/CMR.0b013e32833e3286.

引用本文的文献

1
Suppression of NK Cell Activation by JAK3 Inhibition: Implication in the Treatment of Autoimmune Diseases.JAK3 抑制对 NK 细胞激活的抑制作用:在自身免疫性疾病治疗中的意义。
J Immunol Res. 2023 Dec 8;2023:8924603. doi: 10.1155/2023/8924603. eCollection 2023.
2
Immune-check blocking combination multiple cytokines shown curative potential in mice tumor model.免疫检查点阻断联合多种细胞因子在小鼠肿瘤模型中显示出治疗潜力。
Cancer Med. 2023 Jun;12(12):13573-13585. doi: 10.1002/cam4.6053. Epub 2023 May 18.
3
Focusing on NK cells and ADCC: A promising immunotherapy approach in targeted therapy for HER2-positive breast cancer.

本文引用的文献

1
Systematic review of the immunological landscape of Wilms tumors.肾母细胞瘤免疫格局的系统评价
Mol Ther Oncolytics. 2021 Jul 13;22:454-467. doi: 10.1016/j.omto.2021.06.016. eCollection 2021 Sep 24.
2
Natural Killer Cells in Cancer and Cancer Immunotherapy.自然杀伤细胞在癌症和癌症免疫疗法中的作用。
Cancer Lett. 2021 Nov 1;520:233-242. doi: 10.1016/j.canlet.2021.07.032. Epub 2021 Jul 22.
3
Stromal-like Wilms tumor cells induce human Natural Killer cell degranulation and display immunomodulatory properties towards NK cells.
聚焦 NK 细胞和 ADCC:HER2 阳性乳腺癌靶向治疗中一种有前景的免疫治疗方法。
Front Immunol. 2022 Dec 19;13:1083462. doi: 10.3389/fimmu.2022.1083462. eCollection 2022.
基质样肾母细胞瘤细胞诱导人类自然杀伤细胞脱颗粒,并对自然杀伤细胞表现出免疫调节特性。
Oncoimmunology. 2021 Mar 8;10(1):1879530. doi: 10.1080/2162402X.2021.1879530.
4
Many faces of Wilms Tumor: Recent advances and future directions.肾母细胞瘤的多面性:最新进展与未来方向
Ann Med Surg (Lond). 2021 Mar 7;64:102202. doi: 10.1016/j.amsu.2021.102202. eCollection 2021 Apr.
5
Therapy of lymphoma by immune checkpoint inhibitors: the role of T cells, NK cells and cytokine-induced tumor senescence.免疫检查点抑制剂治疗淋巴瘤:T 细胞、NK 细胞和细胞因子诱导的肿瘤衰老的作用。
J Immunother Cancer. 2021 Jan;9(1). doi: 10.1136/jitc-2020-001660.
6
High-efficient generation of natural killer cells from peripheral blood with preferable cell vitality and enhanced cytotoxicity by combination of IL-2, IL-15 and IL-18.通过 IL-2、IL-15 和 IL-18 的联合使用,从外周血中高效生成具有更好细胞活力和增强细胞毒性的自然杀伤细胞。
Biochem Biophys Res Commun. 2021 Jan 1;534:149-156. doi: 10.1016/j.bbrc.2020.12.012. Epub 2020 Dec 11.
7
CD8+ T-cell lymphocytes infiltration predict clinical outcomes in Wilms' tumor.CD8 + T 细胞淋巴细胞浸润可预测肾母细胞瘤的临床结局。
Tumour Biol. 2020 Dec;42(12):1010428320975976. doi: 10.1177/1010428320975976.
8
Syndromic Wilms tumor: a review of predisposing conditions, surveillance and treatment.综合征性肾母细胞瘤:易患因素、监测与治疗综述
Transl Androl Urol. 2020 Oct;9(5):2370-2381. doi: 10.21037/tau.2020.03.27.
9
Multiomic analysis of cytokines in immuno-oncology.免疫肿瘤学中细胞因子的多组学分析。
Expert Rev Proteomics. 2020 Sep;17(9):663-674. doi: 10.1080/14789450.2020.1845654. Epub 2020 Nov 23.
10
Exploring the NK cell platform for cancer immunotherapy.探索自然杀伤细胞平台在癌症免疫疗法中的应用。
Nat Rev Clin Oncol. 2021 Feb;18(2):85-100. doi: 10.1038/s41571-020-0426-7. Epub 2020 Sep 15.